Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Atlantic Pharmaceuticals completes pre-IND meeting with FDA for abuse-deterrent hydrocodone

Aug. 16, 2013

Orexo begins dosing in two trials evaluating early and long-term treatment with Zubsolv

Aug. 8, 2013

BioDelivery Sciences submits NDA to FDA for Bunavail

Aug. 2, 2013

Signature Therapeutics receives award to advance abuse-deterrent oxycodone

Aug. 2, 2013

Invion begins phase II INV-102 trial

July 26, 2013

Novel drug and drug target for the treatment of addictive disorders characterized

July 24, 2013

Pluristem's PLX cells tested for treatment of radiation poisoning

July 17, 2013

Novel kappa receptor antagonists disclosed by Research Triangle Institute

July 1, 2013

First patient dosed in phase III study of Zubsolv for new indication

June 19, 2013

Neumedicines receives BARDA award for HemaMax

June 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...